Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
作者信息
Simpson Catherine E, Hassoun Paul M
机构信息
Department of Medicine Johns Hopkins University Baltimore, Maryland.
出版信息
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1377-1379. doi: 10.1164/rccm.202203-0537ED.
Abstract
摘要
相似文献
1
Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.肺动脉高压多组学方法的前景与陷阱
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1377-1379. doi: 10.1164/rccm.202203-0537ED.
2
Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension.重新审视KCNA5在肺动脉高压中的作用
Am J Respir Cell Mol Biol. 2023 Aug;69(2):123-125. doi: 10.1165/rcmb.2023-0119ED.
3
[Genetic diagnostics and molecular approaches in pulmonary arterial hypertension].[肺动脉高压的基因诊断与分子方法]
Pneumologie. 2023 Nov;77(11):862-870. doi: 10.1055/a-2145-4663. Epub 2023 Nov 14.
4
Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"?太热？太冷？肺动脉高压中的Wnt信号传导：我们能将其“恰到好处”地治疗吗？
Eur Respir J. 2023 Jun 8;61(6). doi: 10.1183/13993003.00504-2023. Print 2023 Jun.
5
A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance.迈向肺动脉高压患者有意义的试验结果的进一步进展：6分钟步行距离的最小重要差异
Am J Respir Crit Care Med. 2023 Apr 15;207(8):972-974. doi: 10.1164/rccm.202301-0143ED.
6
Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.利用功能遗传学阐明肺动脉高压的分子格局
Am J Respir Crit Care Med. 2020 Aug 15;202(4):488-490. doi: 10.1164/rccm.202004-1411ED.
7
[Current status and progress of research on pediatric pulmonary arterial hypertension].[小儿肺动脉高压的研究现状与进展]
Zhonghua Er Ke Za Zhi. 2024 Mar 2;62(3):278-281. doi: 10.3760/cma.j.cn112140-20230811-00097.
8
Molecular Pathways in Pulmonary Arterial Hypertension.肺高血压的分子途径。
Int J Mol Sci. 2022 Sep 2;23(17):10001. doi: 10.3390/ijms231710001.
9
Continued Progress in Therapy for Pulmonary Arterial Hypertension.肺动脉高压治疗的持续进展。
N Engl J Med. 2023 Apr 20;388(16):1524-1526. doi: 10.1056/NEJMe2300324. Epub 2023 Mar 6.
10
Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data.肺动脉高压与专科护理中心：我们曾有预感；如今我们有了数据。
Chest. 2020 Jul;158(1):28-30. doi: 10.1016/j.chest.2020.03.079. Epub 2020 Jul 2.
引用本文的文献
1
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.肺动脉高压精准医学中诊断与患者特征分析的进展
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251367312. doi: 10.1177/17534666251367312. Epub 2025 Aug 29.
2
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions.肺动脉高压中的循环生物标志物：最新综述与未来方向
JHLT Open. 2024 Aug 23;6:100152. doi: 10.1016/j.jhlto.2024.100152. eCollection 2024 Nov.
3
Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.解析肺动脉高压的表观遗传学景观：对个体化医学发展的启示。
J Transl Med. 2023 Jul 17;21(1):477. doi: 10.1186/s12967-023-04339-5.
本文引用的文献
1
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.从血浆蛋白质组中挖掘肺动脉高压分子病理学的见解。
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1449-1460. doi: 10.1164/rccm.202109-2106OC.
2
Pulmonary Arterial Hypertension.肺动脉高压
N Engl J Med. 2021 Dec 16;385(25):2361-2376. doi: 10.1056/NEJMra2000348.
3
In the balance: how do thrombospondins contribute to the cellular pathophysiology of cardiovascular disease?在平衡中：血小板反应蛋白如何促进心血管疾病的细胞病理生理学？
Am J Physiol Cell Physiol. 2021 Nov 1;321(5):C826-C845. doi: 10.1152/ajpcell.00251.2021. Epub 2021 Sep 8.
4
Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.单细胞研究揭示了两种肺动脉高压大鼠模型与人病理生理学的联系和药物再定位。
Am J Respir Crit Care Med. 2021 Apr 15;203(8):1006-1022. doi: 10.1164/rccm.202006-2169OC.
5
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.全血 RNA 谱与肺动脉高压及临床结局的相关性。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):586-594. doi: 10.1164/rccm.202003-0510OC.
6
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.肺动脉高压风险的遗传决定因素：国际全基因组关联研究和荟萃分析。
Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.
7
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.肺动脉高压患者小高密度脂蛋白颗粒中携带纤维蛋白溶解蛋白的血浆水平降低。
Thorax. 2019 Apr;74(4):380-389. doi: 10.1136/thoraxjnl-2018-212144. Epub 2018 Nov 26.
8
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.PVDOMICS：一项通过表型组学改善肺血管疾病理解的多中心研究。
Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737.
9
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.通过精准医学方法深入了解肺血管疾病。美国国立心肺血液研究所 - 心血管医学研究与教育基金联合研讨会报告。
Am J Respir Crit Care Med. 2017 Jun 15;195(12):1661-1670. doi: 10.1164/rccm.201701-0150WS.
10
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.血浆代谢组学揭示了修饰的转运RNA和生物能量代谢改变与肺动脉高压预后的关联。
Circulation. 2017 Jan 31;135(5):460-475. doi: 10.1161/CIRCULATIONAHA.116.024602. Epub 2016 Nov 21.
Zotero 插件